Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes

NCT07063797 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT07063797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07063797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes
Lead sponsor
Peking Union Medical College Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
July 31, 2027
Enrollment
358 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

fractures, osteoporosis, type 2 diabetes